Best Options Strategy for ABBV
Looking for the best options strategy for AbbVie (ABBV)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ABBV option chain right now, and a simple map from your view on ABBV to the strategy that fits it. Model any of them in the calculator before you trade.
About ABBV
AbbVie (ABBV) is a major company in pharmaceuticals (immunology and aesthetics). Options traders on ABBV tend to watch Skyrizi and Rinvoq sales, the pipeline and earnings, since these can drive large moves in the share price.
ABBV for options traders
AbbVie's options market is defined by structurally low implied volatility — a natural consequence of its defensive revenue base in immunology and aesthetics, anchored by franchises with long patent runways and predictable royalty-like cash flows. IV tends to stay compressed outside of catalysts, making ABBV one of the quieter large-cap pharma names to trade. The sharpest spikes cluster around quarterly earnings and FDA decisions on pipeline assets, as well as any surprise news touching biosimilar competition for its blockbuster immunology drugs, which can jolt IV higher with little warning.
That persistently low baseline IV makes ABBV a natural hunting ground for premium sellers. Long-term shareholders routinely write covered calls to extract income from a slow-moving, dividend-paying name. Short puts appeal to income-focused traders who are comfortable acquiring shares at a lower cost basis. Into earnings, short strangles or iron condors with wide wings can harvest the post-announcement IV crush efficiently. Defined-risk spreads — bull put spreads or bear call spreads — suit traders who want a directional lean without paying full premium in a low-IV environment where outright calls and puts rarely repay their cost on modest moves.
Today's top-scoring strategy for ABBV
Our engine ranks defined-risk strategies on the live ABBV chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $230 | $0.66 |
| Sell | 1× | PUT | $245 | $2.42 |
| Sell | 1× | CALL | $270 | $2.79 |
| Buy | 1× | CALL | $285 | $0.45 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $323 | −$1,086 | −$1,077 | −$1,058 | −$1,032 | −$1,002 |
| $310 | −$1,062 | −$1,027 | −$984 | −$940 | −$898 |
| $297 | −$935 | −$869 | −$811 | −$764 | −$728 |
| $284 | −$580 | −$540 | −$516 | −$505 | −$505 |
| $271 | −$73 | −$130 | −$186 | −$241 | −$294 |
| $258 | $201 | $87 | −$20 | −$116 | −$200 |
| $245 | −$25 | −$99 | −$169 | −$235 | −$295 |
| $232 | −$596 | −$565 | −$548 | −$542 | −$545 |
| $219 | −$993 | −$941 | −$892 | −$850 | −$817 |
| $206 | −$1,084 | −$1,071 | −$1,051 | −$1,025 | −$996 |
| $194 | −$1,089 | −$1,089 | −$1,086 | −$1,080 | −$1,070 |
Live scan from 2026-09-11 · quotes delayed ~15 minutes
Historical backtest: how a Iron Condor on ABBV would have performed
We approximated a Iron Condor on ABBV, entered repeatedly over the past year (93 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real ABBV price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
ABBV is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 26% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on ABBV currently price in about 26% implied volatility, versus roughly 24% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
ABBV's IV Rank is 20/100: implied volatility sits 20% of the way between its 29-day low (24%) and high (34%), and is above 43% of recorded days. Premium is historically cheap, which favours net-debit strategies like long options and debit spreads.
Off that volatility, the options market is pricing a move of about ±$18.34 (±7%) in ABBV by 2026-10-09 — a range of roughly $240 to $276. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on ABBV carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
ABBV options chain highlights: open interest, volume and skew
The live ABBV options chain shows a put/call open-interest ratio of 0.1 (bullish-leaning (more calls)), with at-the-money implied volatility near 25.6%. Open interest clusters at the $270 call — a common resistance "wall" — and the $240 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
Liquidity and tradeability
ABBV options are thinly traded, with wide bid-ask spreads around 10% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
ABBV's next earnings report is due around October 29, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
ABBV pays a dividend of about 2.7% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $454.4B
- Beta (vs market)
- 0.28
- 52-week range
- $190.75–$267.47 (88% up the range)
- Short interest
- 1.2% of float · 4.0 days to cover
Other strong setups for ABBV
If your view on ABBV differs, these also scored well in the latest scan:
- Jelly Roll (POP 50%) Experienced
How to choose an options strategy for ABBV
Start with your outlook on ABBV, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while ABBV stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open ABBV in the free calculator →
Frequently asked questions
What is the best options strategy for ABBV?
It depends on your outlook. Bullish traders often use a long call or bull call spread on ABBV; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are ABBV options liquid enough to trade?
AbbVie (ABBV) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade ABBV options?
Buying a single ABBV call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ABBV or any security. Do your own research.
What does AbbVie do?
AbbVie (ABBV) operates in the Drug Manufacturers - General industry. The "About AbbVie" section above gives a fuller picture of what the company does and how it earns money.
Does AbbVie pay a dividend?
Yes — AbbVie currently pays a dividend yielding about 2.7%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does AbbVie next report earnings?
AbbVie's next earnings are expected around October 29, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to ABBV
Comparing ABBV with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 1 North Waukegan Road, North Chicago, IL, 60064-6400, United States
- Industry
- Drug Manufacturers - General
- Employees
- 57,000
- Phone
- 847 932 7900
- Website
- www.abbvie.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.